Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Calcium channel blocker.
Glycolic acid ester prodrug of indomethacin, NS...
NSAID; COX-1/2 inhibitor.
Trichothecene mycotoxin produced by Fusarium.
Flavanol originally found in Camilla (green tea...
Endogenous neuropeptide, somatostatin analog; s...
NSAID; COX-2 inhibitor.
Antimicrobial peptide found in amphibians.
Phase II enzyme inducer; Nrf2 activator; antiox...
Fluoroquinolone; topoisomerase IV and bacterial...
Synthetic steroid hormone, contraceptive; PR ag...
Oligopeptide found in Actinomycetes; protease i...
PARP inhibitor.
Nitrosourea, DNA cross-linker.
EGFR inhibitor.
Hydroxycinnamic aicd, verbascoside metabolite, ...
Dihydrofolate reductase inhibitor.
VEGF-C/Nrp2 inhibitor. Leukotriene receptor ant...
Smo inhibitor.
Endogenous NMDA receptor antagonist.